Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Liver Diseases and ITPA[original query] |
---|
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR. Hepatology (Baltimore, Md.) 2011 Feb 53 (2): 389-95. Thompson Alexander J, Santoro Rosanna, Piazzolla Valeria, Clark Paul J, Naggie Susanna, Tillmann Hans L, Patel Keyur, Muir Andrew J, Shianna Kevin V, Mottola Leonardo, Petruzzellis Daniela, Romano Mario, Sogari Fernando, Facciorusso Domenico, Goldstein David B, McHutchison John G, Mangia Alessand |
Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir. Hepatology (Baltimore, Md.) 2011 Feb 53 (2): 415-21. Suzuki Fumitaka, Suzuki Yoshiyuki, Akuta Norio, Sezaki Hitomi, Hirakawa Miharu, Kawamura Yusuke, Hosaka Tetsuya, Kobayashi Masahiro, Saito Satoshi, Arase Yasuji, Ikeda Kenji, Kobayashi Mariko, Chayama Kazuaki, Kamatani Naoyuki, Nakamura Yusuke, Miyakawa Yuzo, Kumada Hiromit |
Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3. Hepatology (Baltimore, Md.) 2014 Jun 59 (6): 2131-9. Rembeck Karolina, Waldenström Jesper, Hellstrand Kristoffer, Nilsson Staffan, Nyström Kristina, Martner Anna, Lindh Magnus, Norkrans Gunnar, Westin Johan, Pedersen Court, Färkkilä Martti, Langeland Nina, Buhl Mads Rauning, Mørch Kristine, Christensen Peer Brehm, Lagging Mart |
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response. Hepatology (Baltimore, Md.) 2014 Jun 59 (6): 2152-60. Holmes Jacinta A, Roberts Stuart K, Ali Rachel J, Dore Gregory J, Sievert William, McCaughan Geoffrey W, Crawford Darrell H, Cheng Wendy S, Weltman Martin D, Bonanzinga Sara, Visvanathan Kumar, Sundararajan Vijaya, Desmond Paul V, Bowden D Scott, Matthews Gail V, Thompson Alexander J, |
- Page last reviewed:Feb 1, 2024
- Content source: